Impact of non-surgical periodontal therapy on serum Resistin and periodontal pathogen in periodontitis patients with obesity

Khairunnisa Md Tahir, Ainul Haliza Ab Malek, Rathna Devi Vaithilingam, Roslan Saub, Syarida Hasnur Safii, Mohammad Tariqur Rahman, Fathilah Abdul Razak, Aied M Alabsi, Nor Adinar Baharuddin, Khairunnisa Md Tahir, Ainul Haliza Ab Malek, Rathna Devi Vaithilingam, Roslan Saub, Syarida Hasnur Safii, Mohammad Tariqur Rahman, Fathilah Abdul Razak, Aied M Alabsi, Nor Adinar Baharuddin

Abstract

Background: Non-surgical periodontal therapy (NSPT) known as gold standard treatment in managing periodontitis. The aim of this study was to investigate the response of NSPT in periodontitis subjects who were obese. Clinical parameters of periodontitis, changes in serum resistin and periodontal pathogens in subgingival plaque were compared before and after NSPT in periodontitis subjects who were obese and with normal weight.

Methods: A total of 48 periodontitis subjects (obese, n = 18; normal weight, n = 30) were recruited (hereafter will be referred as participants) to participate into a prospective, before and after clinical trial. Obesity status is defined by body mass index (BMI) criteria (obese: ≥30 kg/ m2; normal weight < 25 kg/m2). Visible Plaque Index (VPI), Gingival Bleeding Index (GBI), Probing Pocket Depth (PPD) and Clinical Attachment Loss (CAL) were recorded; and serum and plaque were collected at baseline and following 12 weeks post-NSPT. Serum resistin level was analyzed using enzyme-linked immune-sorbant assay (ELISA), while detection of periodontal pathogens in dental plaque were carried out using real time PCR (qPCR).

Results: Following NSPT, means VPI and GBI showed significant improvement between obese and normal weight groups (p < 0.05), but no difference in means PPD and CAL was observed between groups. Obesity remained as a predictor for VPI and GBI after adjusting for smoking habit. No significant difference was observed in serum resistin level and mean counts for P. gingivalis, T. forsythia, and P. intermedia between obese and normal weight groups following NSPT.

Conclusions: Regardless of obesity status, NSPT has a significant impact on VPI and GBI in periodontitis subjects. However, the impact of NSPT towards serum resistin and periodontal pathogens was non-significant in those with periodontitis.

Trial registration: This study followed the Consolidation Standards of Reporting Trials Statement and retrospectively registered on 26/11/2015 at clinicaltrials.gov (No. NCT02618486).

Keywords: Cytokine; Obese; Periodontal pathogens; Periodontal therapy; Periodontitis.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study flow diagram

References

    1. Zander HA, Polson AM, Heijl LC. Goals of periodontal therapy*. J Periodontol. 1976;47:261–266. doi: 10.1902/jop.1976.47.5.261.
    1. Slots J, Ashimoto A, Flynn MJ, Li G, Chen C. Detection of putative periodontal in subgingival specimens by 16S ribosomal DNA amplification with the polymerase chain reaction. Clin Inf Dis. 1995;20:304–307. doi: 10.1093/clinids/20.Supplement_2.S304.
    1. Eguchi T, Koshy G, Umeda M, Iwanami T, Suga J, Nomura Y, et al. Microbial changes in patients with acute periodontal abscess after treatment detected by PadoTest. Oral Dis. 2008;14:180–184. doi: 10.1111/j.1601-0825.2007.01370.x.
    1. Asad M, Aziz AWA, Rahman RPC, Harun HAW, Ali TBT, Chinna K, et al. Comparison of nonsurgical periodontal therapy with oral hygiene instruction alone for chronic periodontitis. J Oral Sci. 2017;59:111–120. doi: 10.2334/josnusd.16-0298.
    1. Akram Z, Baharuddin NA, Vaithilingam RD, Rahim ZHA, Chinna K, Krishna VG, et al. Effect of nonsurgical periodontal treatment on clinical periodontal variables and salivary resistin levels in obese Asians. J Oral Sci. 2017;59:93–102. doi: 10.2334/josnusd.16-0127.
    1. Akram Z, Safii SH, Vaithilingam RD, Baharuddin NA, Javed F, Vohra F. Efficacy of non-surgical periodontal therapy in the management of chronic periodontitis among obese and non-obese patients: a systematic review and meta-analysis. Clin Oral Inv. 2016;20:903–914. doi: 10.1007/s00784-016-1793-4.
    1. Kaushal S, Singh AK, Lal N, Das SK, Mahdi AA. Effect of periodontal therapy on disease activity in patients of rheumatoid arthritis with chronic periodontitis. J Oral Biol Cran Res. 2019;9:128–132. doi: 10.1016/j.jobcr.2019.02.002.
    1. Patel SP, Raju PA. Gingival crevicular fluid and serum levels of resistin in obese and non-obese subjects with and without periodontitis and association with single nucleotide polymorphism at−420. J Indian Soc Periodontol. 2014;18:555. doi: 10.4103/0972-124X.142438.
    1. Suresh S, Mahendra J, Singh G, Kumar ARP, Thilagar S, Rao N. Effect of nonsurgical periodontal therapy on plasma-reactive oxygen metabolite and gingival crevicular fluid resistin and serum resistin levels in obese and normal weight individuals with chronic periodontitis. J Indian Soc Periodontol. 2018;22:310–316. doi: 10.4103/jisp.jisp_194_18.
    1. Goncalves TED, Feres M, Zimmermann GS, Faveri M, Figueiredo LC, Braga PG, et al. Effects of scaling and root planning on clinical response and serum levels of adipocytokines in patients with obesity and chronic periodontitis. J Periodontol. 2015;86:53–61. doi: 10.1902/jop.2014.140266.
    1. Suresh S, Mahendra J, Kumar A, Singh G, Jayaraman S, Paul R. Comparative analysis of subgingival red complex bacteria in obese and normal weight subjects with and without chronic periodontitis. J Indian Soc Periodontol. 2017;21:186–191. doi: 10.4103/jisp.jisp_241_17.
    1. Haffajee AD, Socransky SS. Relation of body mass index, periodontitis and Tannerella forsythia. J Clin Periodontol. 2009;36:89–99. doi: 10.1111/j.1600-051X.2008.01356.x.
    1. Filková M, Haluzík M, Gay S, Šenolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157–170. doi: 10.1016/j.clim.2009.07.013.
    1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–312. doi: 10.1038/35053000.
    1. Akram Z, Rahim ZHA, Ali TBT, Shahdan MSA, Baharuddin NA, Vaithilingam RD, et al. Resistin as a potential biomarker for chronic periodontitis: a systematic review and meta analysis. Arch Oral Biol. 2017;72:311–320. doi: 10.1016/j.archoralbio.2016.08.016.
    1. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91:914–920. doi: 10.1177/0022034512457373.
    1. WHO. Global database on body mass index; 2012.
    1. Altay U, Gurgan CA, Agbaht K. Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity. J Periodontol. 2013;84:13–23. doi: 10.1902/jop.2012.110646.
    1. Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Res Meth. 2007;39:175–191. doi: 10.3758/BF03193146.
    1. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25:229–235.
    1. Swierkot K, Nonnenmacher CI, Mutters R, Flores-de-Jacoby L, Mengel R. One-stage full-mouth disinfection versus quadrant and full-mouth root planing. J Clin Periodontol. 2009;36:240–249. doi: 10.1111/j.1600-051X.2008.01368.x.
    1. Raman RP, Taiyeb-Ali TB, Chan SP, Chinna K, Vaithilingam RD. Effect of nonsurgical periodontal therapy verses oral hygiene instructions on type 2 diabetes subjects with chronic periodontitis: a randomised clinical trial. BMC Oral Health. 2014;14:1–10. doi: 10.1186/1472-6831-14-79.
    1. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. Comparison of real-time PCR and culture for detection of Porphyromonas gingivalis in subgingival plaque samples. J Clin Mic. 2003;41:4950–4954. doi: 10.1128/JCM.41.11.4950-4954.2003.
    1. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Imm Med Mic. 2005;45:191–199. doi: 10.1016/j.femsim.2005.03.011.
    1. Strohm TF, Alt KW. Periodontal disease—etiology, classification and diagnosis. In Den Anth. 1998:227–46.
    1. WHO. The WHO global oral health data bank. Geneva: World Health Organization; 2007.
    1. Khader YS, Bawadi HA, Haroun TF, Alomari M, Tayyem RF. The association between periodontal disease and obesity among adults in Jordan. J Clin Periodonto. 2009;36:18–24. doi: 10.1111/j.1600-051X.2008.01345.x.
    1. Khan S, Saub R, Vaithilingam RD, Safii SH, Vethakkan SR, Baharuddin NA. Prevalence of chronic periodontitis in an obese population: a preliminary study. BMC Oral Health. 2015;15:114. doi: 10.1186/s12903-015-0098-3.
    1. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. 2001;2:141–147. doi: 10.1046/j.1467-789x.2001.00031.x.
    1. Chaffee BW, Weston SJ. Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol. 2010;81:1704–1724. doi: 10.1902/jop.2010.100321.
    1. Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R, Kebschull M, et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol. 2009;36:287–294. doi: 10.1111/j.1600-051X.2009.01382.x.
    1. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol. 2003;30:334–340. doi: 10.1034/j.1600-051X.2003.00282.x.
    1. Tonetti MS, D’Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. New England J Med. 2007;356:911–920. doi: 10.1056/NEJMoa063186.
    1. D’Aiuto F, Parkar M, Tonetti MS. Periodontal therapy: a novel acute inflammatory model. Inflam Res. 2005;54:412–414. doi: 10.1007/s00011-005-1375-4.
    1. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007;43:160–232. doi: 10.1111/j.1600-0757.2006.00178.x.
    1. Ivić-Kardum M, Jurak I, Gall-Trošelj K, Pavelić K, Aurer A, Ibrahimagić L. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases. Acta Stoma Croatica. 2001;35:39–42.
    1. Predin T, Djuric M, Nikolic N, Mirnic J, Gusic I, Petrovic D, et al. Clinical and microbiological effects of quadrant versus full-mouth root planning a randomized study. J Dent Sci. 2014;9:400–406. doi: 10.1016/j.jds.2013.06.005.
    1. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. J Clin Periodontol. 1998;25:112–124. doi: 10.1111/j.1600-051X.1998.tb02417.x.
    1. Buzinin Samira Mukhtar, Alabsi Aied Mohammed, Tan Alexander Tong Boon, Vincent-Chong Vui King, Swaminathan Dasan. Effects of Nonsurgical Periodontal Therapy on Clinical Response, Microbiological Profile, and Glycemic Control in Malaysian Subjects with Type 1 Diabetes. The Scientific World Journal. 2014;2014:1–7. doi: 10.1155/2014/232535.
    1. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol. 2005;76:2075–2084. doi: 10.1902/jop.2005.76.11-S.2075.
    1. Suvan J, Petrie A, Moles DR, Nibali L, Patel K, Darbar U, et al. Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res. 2014;93:49–54. doi: 10.1177/0022034513511084.
    1. Bergström J. Cigarette smoking as a risk factor in chronic periodontal disease. J Clin Periodontol. 1989;17:245–247.
    1. Bergström J. Tobacco smoking and chronic destructive periodontal disease. Odontol. 2004;92:1–8. doi: 10.1007/s10266-004-0043-4.
    1. Bergström J, Preber H. Tobacco use as a risk factor. J Periodontol. 1994;65:545–550. doi: 10.1902/jop.1994.65.5s.545.
    1. Zuza EP, Barroso EM, Carrareto ALV, Pires JR, Carlos IZ, Theodoro LH, et al. The role of obesity as a modifying factor in patients undergoing non-surgical periodontal therapy. J Periodontol. 2011;82:676–682. doi: 10.1902/jop.2010.100545.
    1. Haffajee AD, Socransky SS, Goodson JM. Clinical parameters as predictors of destructive periodontal disease activity. J Clin Periodontol. 1983;10:257–225. doi: 10.1111/j.1600-051X.1983.tb01274.x.
    1. Petersen PE, Ogawa H. Strengthening the prevention of periodontal disease: the WHO approach. J Periodontol. 2005;76:2187–2193. doi: 10.1902/jop.2005.76.12.2187.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren